2 ASX ETFs I'd buy for dividend income

These diversified portfolios could provide an attractive and growing source of income.

| More on:
ETF written on cubes sitting on piles of coins.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • There aren’t too many ASX ETFs then can provide a mixture of dividends and growth, but the two below could do it
  • Betashares FTSE 100 ETF is invested in 100 of the largest businesses listed in the UK
  • Australian Ex-20 Portfolio Diversifier ETF excludes the largest 20 ASX shares and is invested in the next 180

The ASX exchange-traded fund (ETF) sector of the share market can be a fruitful place to find opportunities for diversification, dividend income and growth.

Some ETFs are known for being more growth-focused, such as the iShares S&P 500 ETF (ASX: IVV) or the Vanguard Diversified High Growth Index ETF (ASX: VDHG).

I don't mind the ETFs that are focused on the large ASX shares, such as Vanguard Australian Shares Index ETF (ASX: VAS) or the BetaShares Australia 200 ETF (ASX: A200). But I don't think they have a lot of growth potential because of the nature of large ASX bank shares and large ASX mining shares.

There are a group of ASX ETFs that could provide a mixture of solid dividend income and decent capital growth. Here I'm going to tell you about two of them.

Betashares FTSE 100 ETF (ASX: F100)

The idea behind this ETF is that it tracks an index of 100 of the largest businesses that are trading on the London Stock Exchange.

While the ASX is heavily weighted to resources and banks, the F100 ETF has a more healthy split between the different sectors in my opinion. There are currently six sectors with a weighting of more than 10%: consumer staples (19.2%), financials (17.6%), energy (13.1%), healthcare (12.4%), materials (10.7%) and industrials (10.3%).

Investors may recognise some of the biggest 10 positions in the portfolio of AstraZeneca, Shell, HSBC, Unilever, BP, Diageo, British American Tobacco, GSK, Glencore and Rio Tinto.

BetaShares says that the ASX ETF's distribution yield, which is based on the last 12 months of distributions, is around 3%. That's not huge, but it's more than double the dividend yield of the US shares-focused iShares S&P 500 ETF.

The ETF is delivering capital growth, though we can never know when volatility may hit. As we can see on the graph below, the Betashares FTSE 100 ETF has risen by over 11% in 2023 to date.

Australian Ex-20 Portfolio Diversifier ETF (ASX: EX20)

As the name suggests, this ASX ETF is invested in ASX shares, but a key difference to ones like the VAS ETF is that it excludes the biggest 20 ASX shares and invests in the next 180 names. In other words, it's not invested in names like Commonwealth Bank of Australia (ASX: CBA), BHP Group Ltd (ASX: BHP) and CSL Limited (ASX: CSL).

What are the benefits of this? Firstly, the EX20 ETF reduces portfolio concentration to a few large banks and miners – it can enable diversification.

With this 180-name portfolio, I think it can deliver a bit more growth. Larger businesses are normally quite far along on their growth journey, whereas the smaller ones could have more growth potential.

As of 18 May 2023, these were the biggest 10 positions: Brambles Limited (ASX: BXB), South32 Ltd (ASX: S32), James Hardie Industries plc (ASX: JHX), Sonic Healthcare Ltd (ASX: SHL), Cochlear Limited (ASX: COH), Suncorp Group Ltd (ASX: SUN), Northern Star Resources Ltd (ASX: NST), Origin Energy Ltd (ASX: ORG),  Scentre Group (ASX: SCG) and ResMed Inc (ASX: RMD).

Seeing as this article is about passive income, now let's look at the most important part of the ASX ETF – the dividend yield. BetaShares said that the last 12 month distribution yield is 3.1% or 3.8% when grossed up for franking credits.

If the underlying EX20 ETF's businesses can achieve attractive earnings growth over time, then it could mean that the dividends could grow at a faster pace.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Cochlear, and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Cochlear, Sonic Healthcare, and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ETFs

Magnifying glass on ETF text next to a calculator and notepad.
ETFs

4 super ASX ETFs to buy this month

These ETFs could be great options for investors next month. But why?

Read more »

Man looking at an ETF diagram.
ETFs

Invest $10,000 into these ASX ETFs in October

Here's why these could be among the best funds to buy right now.

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
ETFs

4 ASX ETFs that hit new 52-week highs today

These ETFs provide exposure to the gold price and companies in emerging markets.

Read more »

Man smiling at a laptop because of a rising share price.
ETFs

Considering the Betashares Nasdaq 100 ETF (NDQ)? Here's what you're buying

The NDQ ETF has delivered strong results with an impressive portfolio.

Read more »

Person handing out $50 notes, symbolising ex-dividend date.
ETFs

3 ASX ETFs to buy for income in October

Looking for an income boost? Check out these ETFs this month.

Read more »

Cubes placed on a Notebook with the letters "ETF" which stands for "Exchange traded funds".
ETFs

Guess which ASX ETF has rocketed 31% in 2 weeks?

How did this ETF rise so much in so little time?

Read more »

ETF written in white on a grass background.
ETFs

Overinvested in the BetaShares Australia 200 ETF (A200)? Try these 2 ASX ETFs

There’s a big world of ETFs to choose from.

Read more »

Woman sitting at a desk shrugs.
ETFs

The pros and cons of buying the Vanguard Australian Shares Index ETF (VAS) in October

What are the positives and negatives of the Australian share market right now?

Read more »